Log In
BCIQ
Print this Print this
 

TG6002

  Manage Alerts
Collapse Summary General Information
Company Transgene S.A.
DescriptionViral vector expressing the FCU1 gene.
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$9.7M

$9.7M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/06/2012

$9.7M

$9.7M

0

Get a free BioCentury trial today